Related Experiment Videos
Reduction in cerebral arteriolar oxygen consumption by arachidonate
The American Journal of Physiology
|April 1, 1985
Summary
High concentrations of arachidonate and 15-hydroperoxy-eicosatetraenoic acid (15-HPETE) reduce oxygen consumption in feline cerebral arterioles. This effect is mediated by oxygen radicals generated within the vessel wall.
Area of Science:
- Biochemistry
- Physiology
- Vascular Biology
Background:
- Cerebral arterioles play a crucial role in regulating brain blood flow.
- Oxygen consumption by vascular tissues is vital for maintaining cellular function.
- Arachidonic acid metabolites are implicated in various physiological and pathological processes.
Purpose of the Study:
- To investigate the impact of arachidonate and 15-HPETE on cerebral arteriole oxygen consumption.
- To determine the mechanism underlying the observed effects on oxygen consumption.
- To identify the source of radical generation in the cerebral vasculature.
Main Methods:
- Cartesian diver microrespirometry was used to measure oxygen consumption in feline cerebral arterioles.
- In vitro incubation with arachidonate, 15-HPETE, xanthine oxidase, and acetaldehyde.
- Assessment of radical scavenging by superoxide dismutase (SOD) and catalase.
- Evaluation of cyclooxygenase and lipoxygenase inhibitor effects.
Main Results:
- Arachidonate and 15-HPETE significantly decreased oxygen consumption in cerebral arterioles.
- The inhibitory effect was abolished by superoxide dismutase (SOD) and catalase, indicating oxygen radical involvement.
- Xanthine oxidase/acetaldehyde system also reduced oxygen consumption, partially inhibited by SOD and catalase.
- Cyclooxygenase inhibitors partially blocked the arachidonate effect, while lipoxygenase inhibitors were toxic.
Conclusions:
- High concentrations of arachidonate and 15-HPETE depress cerebral arteriole oxygen consumption through an oxygen radical-mediated pathway.
- Oxygen radicals are generated intrinsically within the vessel wall, independent of brain parenchyma or blood components.
- This mechanism highlights a novel pathway for vascular dysfunction in the brain.